Sjogren's syndrome presenting as remitting seronegative symmetric synovitis with pitting edema (RS3PE).

od Choi, Young Mi, Sheen, Dong Hyuk, Lee, Yun Jong, Lee, Eun Bong, Song, Yeong Wook
Izdano 2003

Serum Exosomal miRNA-1915-3p Ιs Correlated With Disease Activity of Korean Rheumatoid Arthritis

od LIM, MI-KYOUNG, YOO, JIHYUNG, SHEEN, DONG-HYUK, IHM, CHUNHWA, LEE, SANG KWANG, KIM, SOON AE
izdano v In Vivo (2020)

Long-term Treatment with Anti-platelet Agents for Collagen-induced Arthritis Improves Radiological Findings

od Kim, Chan, Kim, Toyou, Yoo, Jihyung, Sheen, Dong-Hyuk, Lee, Sang Kwang, Choi, Eun-Hye, Chun, Tong Jin, Kang, Seong-wook, Shim, Seung-Cheol, Lim, Mi-Kyoung
izdano v Osong Public Health Res Perspect (2017)

Gene Expression Profile of T-cell Receptors in the Synovium, Peripheral Blood, and Thymus during the Initial Phase of Collagen-induced Arthritis

od Kim, Ji-Young, Lim, Mi Kyoung, Sheen, Dong Hyuk, Kim, Chan, Lee, So Young, Park, Hyo, Lee, Min Ji, Lee, Sang Kwang, Yang, Yun Sik, Shim, Seung Cheol
Izdano 2011

Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab

od Lee, Sang‐Hoon, Park, Won, Won Lee, Sung, Kim, Hyun Ah, Choe, Jung‐Yoon, Lee, Sang‐Heon, Lee, Shin‐Seok, Park, Sung‐Hwan, Park, Min‐Chan, Sheen, Dong‐Hyuk, Lee, Hye Soon, Lee, Yeon‐Ah, Lee, Yusun, Kim, Tae‐Hwan
izdano v Int J Rheum Dis (2020)

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

od Yoo, Dae Hyun, Suh, Chang-Hee, Shim, Seung Cheol, Jeka, Slawomir, Cons-Molina, Francisco Fidencio, Hrycaj, Pawel, Wiland, Piotr, Lee, Eun Young, Medina-Rodriguez, Francisco G, Shesternya, Pavel, Radominski, Sebastiao, Stanislav, Marina, Kovalenko, Volodymyr, Sheen, Dong Hyuk, Myasoutova, Leysan, Lim, Mie Jin, Choe, Jung-Yoon, Lee, Sang Joon, Lee, Sung Young, Kwon, Taek Sang, Park, Won
izdano v Ann Rheum Dis (2017)

Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 7...

od Yoo, Dae Hyun, Suh, Chang-Hee, Shim, Seung Cheol, Jeka, Slawomir, Molina, Francisco Fidencio Cons, Hrycaj, Pawel, Wiland, Piotr, Lee, Eun Young, Medina-Rodriguez, Francisco G., Shesternya, Pavel, Radominski, Sebastiao, Stanislav, Marina, Kovalenko, Volodymyr, Sheen, Dong Hyuk, Myasoutova, Leysan, Lim, Mie Jin, Choe, Jung-Yoon, Lee, Sang Joon, Lee, Sung Young, Kim, Sung Hwan, Park, Won
izdano v BioDrugs (2017)

Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity

od Shin, Kichul, Kim, Sung Soo, Lee, Sang-Heon, Hong, Seung-Jae, Choi, Sung Jae, Choe, Jung-Yoon, Lee, Seung-Geun, Cha, Hoon-Suk, Lee, Eun Young, Park, Sung-Hwan, Hur, Jin-Wuk, Na, Sung Soo, Suh, Chang-Hee, So, Min Wook, Choi, Seung Won, Sheen, Dong-Hyuk, Park, Won, Lee, Shin-Seok, Ryu, Wan Hee, Kim, Jin Seok, Song, Jung Soo, Lee, Hye Soon, Kim, Seong Ho, Yoo, Dae-Hyun
izdano v Korean J Intern Med (2020)

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC...

od Park, Min-Chan, Matsuno, Hiroaki, Kim, Jinseok, Park, Sung-Hwan, Lee, Sang-Heon, Park, Yong-Beom, Lee, Yun Jong, Lee, Sang-Il, Park, Won, Sheen, Dong Hyuk, Choe, Jung-Yoon, Choi, Chan-Bum, Hong, Seung-Jae, Suh, Chang-Hee, Lee, Shin-Seok, Cha, Hoon-Suk, Yoo, Bin, Hur, Jin-Wuk, Kim, Geun-Tae, Yoo, Wan-Hee, Baek, Han Joo, Shin, Kichul, Shim, Seung Cheol, Yang, Hyung-In, Kim, Hyun Ah, Park, Kyung-Su, Choi, In Ah, Lee, Jisoo, Tomomitsu, Masato, Shin, Seonghye, Lee, Jiyoon, Song, Yeong Wook
izdano v Arthritis Res Ther (2019)